Generics Bulletin
HBW Insight
In Vivo
Medtech Insight
Pink Sheet
Scrip
Close
Search
Search
In Vivo
Generics Bulletin
HBW Insight
Medtech Insight
Pink Sheet
Scrip
US FDA’s Woodcock Rejects Firewall Between Presubmission Advice And Application Review
Feb 19 2021
•
By
Sue Sutter
Public Citizen wanted a firewall separating CDER staff who provide presubmission advice from those who review drug applications. • Source: Shutterstock
More from US FDA
More from Agency Leadership